US OptionsDetailed Quotes
QTTB241220P45000
- 25.50
- 0.000.00%
15min DelayClose Dec 10 16:00 ET
0.00High0.00Low
25.50Open25.50Pre Close0 Volume92 Open Interest45.00Strike Price0.00Turnover614.17%IV20.11%PremiumDec 20, 2024Expiry Date20.59Intrinsic Value100Multiplier9DDays to Expiry4.91Extrinsic Value100Contract SizeAmericanOptions Type-0.5525Delta0.0165Gamma0.96Leverage Ratio-0.5163Theta-0.0086Rho-0.53Eff Leverage0.0154Vega
Q32 Bio Stock Discussion
Sign in to post a comment
NOTE: I don’t have time to include those in my watchlist which didnt run. Just go back to it because those stocks will go usually after days or a week.
Sorry I am sleepy cant finish the list.
$Rigetti Computing (RGTI.US)$ PR today 12/10: Quantum Machines And Rigetti Computing Announces The Application Of AI To Automate The Calibration Of A Quantum Computer. Up after hours. SI 13.89%, 0 shares LTB
$SEALSQ Corp (LAES.US)$ PR 12/10: Partnership with IC’ALPS to d...
Sorry I am sleepy cant finish the list.
$Rigetti Computing (RGTI.US)$ PR today 12/10: Quantum Machines And Rigetti Computing Announces The Application Of AI To Automate The Calibration Of A Quantum Computer. Up after hours. SI 13.89%, 0 shares LTB
$SEALSQ Corp (LAES.US)$ PR 12/10: Partnership with IC’ALPS to d...
54
9
4
$Q32 Bio (QTTB.US)$
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Tuesday, 10th December at 4:05 pm
-- SIGNAL-AA demonstrated encouraging clinical activity of bempikibart in patients with alopecia areata (AA), including improvement from baseline on SALT score and meaningful achievement of SALT-20 response --
-- SIGNAL-AD Phase 2a clinical trial in atopic dermatitis demonstrated promising findings in Part A but did not meet ...
Q32 Bio Provides Bempikibart Program Update, Including Next Steps for Advancing Alopecia Areata Development Program
Tuesday, 10th December at 4:05 pm
-- SIGNAL-AA demonstrated encouraging clinical activity of bempikibart in patients with alopecia areata (AA), including improvement from baseline on SALT score and meaningful achievement of SALT-20 response --
-- SIGNAL-AD Phase 2a clinical trial in atopic dermatitis demonstrated promising findings in Part A but did not meet ...
$Q32 Bio (QTTB.US)$ nice bull flag on daily.. has it rested enough?? 🤔 could be a nice swing.. TP $60??
$Humacyte (HUMA.US)$ anything approaching home run (>100%) in a month near 1 year resistance above or below in very bullish characteristics, worth keeping in watchlist
No comment yet
AW138 : thank you sir, always appreciate your posts
DaTrader AW138 : I second that
WILLEE9ice : tons of thanks master, you have has done the jobs
Jenna Ragan : Thank you kindly
Tottigol10 : I can't understand unfortunately..any recommendations on where i can start to study and get more into it?
View more comments...